Overall, IFNAR1 blockade enhances anti-inflammatory signaling and cell survival in monocyte-derived macrophages during CCl4-induced liver fibrosis, as evidence by increased M2/M1 ratios and P-STAT3 activation. Here, IFNAR1 is linked to Hepatic fibrosis.